A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD (AURORA)

This study has been completed.
Sponsor:
Collaborators:
Beijing DMS Pharma Ltd.
The Digital Angiography Reading Center (DARC)
Information provided by (Responsible Party):
Chengdu Kanghong Biotech Co.,Ltd.
ClinicalTrials.gov Identifier:
NCT01157715
First received: July 6, 2010
Last updated: March 26, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)